Cargando…
Model‐based meta‐analysis of non‐small cell lung cancer with standard of care PD‐1 inhibitors and chemotherapy for early development decision making
Single‐arm cohorts/trials are often used in early phase oncology programs to support preliminary clinical activity assessments for investigational products, administered alone or in combination with standard of care (SOC) agents. Benchmarking clinical activity of those combinations against other tre...
Autores principales: | Turner, David C., Wada, Russ, Zhou, Helen, Wang, Xiaowei, de Greef, Rik, Valiathan, Chandni, Zhang, Lindsey, Zhang, Nancy, Kuchimanchi, Mita, Chen, Tai‐Tsang, Ballas, Marc, Visser, Sandra A. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681483/ https://www.ncbi.nlm.nih.gov/pubmed/36642813 http://dx.doi.org/10.1002/psp4.12917 |
Ejemplares similares
-
Exposure–response analysis of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukaemia and comparison with standard of care chemotherapy
por: Kuchimanchi, Mita, et al.
Publicado: (2019) -
Translational Pharmacokinetic/Pharmacodynamic Modeling of Tumor Growth Inhibition Supports Dose‐Range Selection of the Anti–PD‐1 Antibody Pembrolizumab
por: Lindauer, A, et al.
Publicado: (2016) -
Standardized and reproducible measurement of decision-making in mice
por: Aguillon-Rodriguez, Valeria, et al.
Publicado: (2021) -
Correction: Standardized and reproducible measurement of decision-making in mice
por: Aguillon, Valeria, et al.
Publicado: (2022) -
Development of a Population Pharmacokinetic Model for the Diroximel Fumarate Metabolites Monomethyl Fumarate and 2-Hydroxyethyl Succinimide Following Oral Administration of Diroximel Fumarate in Healthy Participants and Patients with Multiple Sclerosis
por: Kuchimanchi, Mita, et al.
Publicado: (2022)